Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation
NCT06571214Phase 4Not yet recruiting
- Sponsor
- Nanjing University
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lutropin alfa in infertility (2 arms), sponsored by Nanjing University. Primary endpoint: Good quality embryo rate (cleavage stage). Planned start Sep 2024; status: not yet recruiting.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06571214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06571214.